1. Home
  2. AIMD
  3. AIMD News

Latest Ainos Inc. (AIMD) News on May 16, 2025

AIMD

ACCESS Newswire

2 days ago

Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

AIMD

ACCESS Newswire

4 days ago

Ainos Reports First Quarter 2025 Financial Results

AIMD

ACCESS Newswire

11 days ago

Atossa Therapeutics and Ainos Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

AIMD

ACCESS Newswire

16 days ago

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

AIMD

ACCESS Newswire

23 days ago

Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly

Ainos and ugo Complete First Robotic Smell Integration in Japan
AIMD

ACCESS Newswire

25 days ago

Ainos and ugo Complete First Robotic Smell Integration in Japan

AIMD

ACCESS Newswire

a month ago

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

AIMD

ACCESS Newswire

a month ago

Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling

AIMD

ACCESS Newswire

2 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025

AIMD

ACCESS Newswire

2 months ago

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More

AIMD

ACCESS Newswire

2 months ago

Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing

Ainos Full Year 2024 Earnings: US$1.56 loss per share (vs US$3.36 loss in FY 2023)
AIMD

Simply Wall St.

2 months ago

Ainos Full Year 2024 Earnings: US$1.56 loss per share (vs US$3.36 loss in FY 2023)

AIMD

ACCESS Newswire

2 months ago

Ainos Reports Full Year 2024 Financial Results

AIMD

ACCESS Newswire

2 months ago

Water Tower Research Highlights Ainos & ugo Partnership: The Final Sense for Robots - AI Smell is Here

Ainos, ugo to develop robot with sense of smell
AIMD

TipRanks

2 months ago

Ainos, ugo to develop robot with sense of smell

Ainos and ugo to Develop the World's First Robot With a Sense of Smell
AIMD

ACCESS Newswire

2 months ago

Ainos and ugo to Develop the World's First Robot With a Sense of Smell

AIMD

ACCESS Newswire

4 months ago

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

AIMD

ACCESS Newswire

4 months ago

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

AIMD

ACCESS Newswire

4 months ago

Ainos Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

AIMD

ACCESS Newswire

4 months ago

Ainos Unveils AI Nose for Robotics: Invites Global Robotics Companies to Join Forces in Shaping the Future of Smell-Enabled Robots

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
AIMD

ACCESSWIRE

5 months ago

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA
AIMD

ACCESSWIRE

5 months ago

Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

AIMD

ACCESSWIRE

5 months ago

Ainos Joins Webull Corporate Connect Service Platform to Enhance Investor Engagement

AIMD

ACCESSWIRE

5 months ago

Water Tower Research Underscores Ainos' Partnership With Taiwan Tanabe Seiyaku for VELDONA Manufacturing and Marketing

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug
AIMD

Newsfile

5 months ago

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren's Syndrome Drug

AIMD

ACCESSWIRE

6 months ago

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren's Trial Alongside 3Q24 Earnings and Developments

AIMD

ACCESSWIRE

6 months ago

Ainos Announces IRB Approval for Sjögren’s Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025

Ainos Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.73 loss in 3Q 2023)
AIMD

Simply Wall St.

6 months ago

Ainos Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.73 loss in 3Q 2023)

AIMD

ACCESSWIRE

6 months ago

Ainos Takes Decisive Action to Protect Stockholder Interests and Combat Potential Illegal Trading Activities

AIMD

ACCESSWIRE

6 months ago

Ainos Reports Third Quarter 2024 Financial Results

AIMD

ACCESSWIRE

7 months ago

Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets

AIMD

ACCESSWIRE

7 months ago

Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast

AIMD

ACCESSWIRE

7 months ago

Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies

AIMD

ACCESSWIRE

8 months ago

Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA

AIMD

ACCESSWIRE

8 months ago

Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome

AIMD

ACCESSWIRE

8 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options

AIMD

ACCESSWIRE

8 months ago

Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts

AIMD

ACCESSWIRE

8 months ago

Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA

AIMD

ACCESSWIRE

8 months ago

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention

AIMD

ACCESSWIRE

9 months ago

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter
AIMD

ACCESSWIRE

9 months ago

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety
AIMD

ACCESSWIRE

9 months ago

Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety

AIMD

ACCESSWIRE

9 months ago

Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024

AIMD

ACCESSWIRE

9 months ago

Ainos Secures Exclusive Multi-Regions Invention Patent Licenses from Strategic Partner to Bolster AI Nose and Point-Of-Care Testing

Ainos Second Quarter 2024 Earnings: US$0.49 loss per share (vs US$0.58 loss in 2Q 2023)
AIMD

Simply Wall St.

9 months ago

Ainos Second Quarter 2024 Earnings: US$0.49 loss per share (vs US$0.58 loss in 2Q 2023)

AIMD

ACCESSWIRE

9 months ago

Ainos Concludes Growth Financing From Lind Partners

AIMD

ACCESSWIRE

9 months ago

Ainos Reports Second Quarter 2024 Financial Results

AIMD

ACCESSWIRE

10 months ago

Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug

AIMD

ACCESSWIRE

a year ago

Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA

AIMD

ACCESSWIRE

a year ago

Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market

AIMD

ACCESSWIRE

a year ago

Ainos Reports First Quarter 2024 Financial Results

AIMD

ACCESSWIRE

a year ago

Ainos Raises $9 Million in Growth Capital with Existing Shareholder

Ainos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)
AIMD

Simply Wall St.

a year ago

Ainos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)

AIMD

ACCESSWIRE

a year ago

Ainos Reports Full Year 2023 Financial Results

Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing
AIMD

GlobeNewswire

a year ago

Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing

Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024
AIMD

GlobeNewswire

a year ago

Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024

AIMD

ACCESSWIRE

a year ago

Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th
AIMD

GlobeNewswire

a year ago

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th

Be Wary Of Meihua International Medical Technologies (NASDAQ:MHUA) And Its Returns On Capital
AIMD

Simply Wall St.

a year ago

Be Wary Of Meihua International Medical Technologies (NASDAQ:MHUA) And Its Returns On Capital

Two New Knightscope Security Robots Now Protecting Houston Property
AIMD

Business Wire

a year ago

Two New Knightscope Security Robots Now Protecting Houston Property

AIMD

GlobeNewswire

a year ago

Diamond Equity Research Releases Update Note on YS Biopharma Co., Ltd. (NASDAQ: YS)

AIMD

ACCESSWIRE

a year ago

Ainos Announces $1.75 Million Follow-On Funding

Newton Shafts, a Division of Sacks Parente, Announces the Signing of PGA TOUR Champions Player Ken Duke as its First Player to its Roster
AIMD

GlobeNewswire

a year ago

Newton Shafts, a Division of Sacks Parente, Announces the Signing of PGA TOUR Champions Player Ken Duke as its First Player to its Roster

Wearable Devices: The Mudra Band Featured by Leading Tech Magazines, Mashable and VentureBeat
AIMD

GlobeNewswire

a year ago

Wearable Devices: The Mudra Band Featured by Leading Tech Magazines, Mashable and VentureBeat

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck
AIMD

GlobeNewswire

a year ago

REE Completes U.S. Certification of Full-by-Wire Vehicles and Begins Customer Deliveries of its P7-C Electric Truck

Worksport Announces SOLIS Solar Truck Cover will be Available for FORD, RAM (Stellantis) & GM
AIMD

GlobeNewswire

a year ago

Worksport Announces SOLIS Solar Truck Cover will be Available for FORD, RAM (Stellantis) & GM

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
AIMD

GlobeNewswire

a year ago

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
AIMD

GlobeNewswire

a year ago

Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
AIMD

GlobeNewswire

a year ago

Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
AIMD

GlobeNewswire

a year ago

Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
AIMD

GlobeNewswire

a year ago

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

Foghorn Therapeutics Announces CFO Departure
AIMD

GlobeNewswire

a year ago

Foghorn Therapeutics Announces CFO Departure

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC
AIMD

GlobeNewswire

a year ago

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
AIMD

Business Wire

a year ago

Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.

AIMD

ACCESSWIRE

a year ago

Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell
AIMD

ACCESSWIRE

a year ago

Ainos, Nisshinbo Micro Devices and Inabata Initiate Phase 2 of VOC Co-development Powered by AI Nose, Accelerating the Digitalization of Smell

Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
AIMD

PR Newswire

a year ago

Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024

11 Popular Penny Stocks on Robinhood
AIMD

Insider Monkey

a year ago

11 Popular Penny Stocks on Robinhood

EPOW Lead in Establishing National Battery Industry Standard Policy, Highlighting Its Position as a Benchmark in Technological Innovation, Product Quality and Management Efficiency in the Industry
AIMD

GlobeNewswire

a year ago

EPOW Lead in Establishing National Battery Industry Standard Policy, Highlighting Its Position as a Benchmark in Technological Innovation, Product Quality and Management Efficiency in the Industry

Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
AIMD

Business Wire

a year ago

Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences

AIMD

InvestorPlace

a year ago

AMC Stock: This Dog With Fleas Just Won’t Die. Should You Buy? NO.

AIMD

ACCESSWIRE

a year ago

Ainos, Inc. Announces Stock Consolidation

11 Best Stocks to Buy for the Next 10 Years
AIMD

Insider Monkey

a year ago

11 Best Stocks to Buy for the Next 10 Years

Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024
AIMD

PR Newswire

a year ago

Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024

La Rosa Implements Final Offer to Deliver Transparency in Real Estate Transactions
AIMD

GlobeNewswire

a year ago

La Rosa Implements Final Offer to Deliver Transparency in Real Estate Transactions

Hycroft Regains Compliance with Nasdaq Listing Requirements
AIMD

PR Newswire

a year ago

Hycroft Regains Compliance with Nasdaq Listing Requirements

POET Technologies Issues Letter to Shareholders
AIMD

GlobeNewswire

a year ago

POET Technologies Issues Letter to Shareholders

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
AIMD

PR Newswire

a year ago

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split
AIMD

PR Newswire

a year ago

PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split

AIMD

Business Wire

a year ago

Usio Announces Strategic Partnership with Leading Benefits Administrator, Genius Avenue

Small Stocks, Big Potential: 7 Penny Stocks Poised for Major Gains in 2024
AIMD

InvestorPlace

a year ago

Small Stocks, Big Potential: 7 Penny Stocks Poised for Major Gains in 2024

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
AIMD

GlobeNewswire

a year ago

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

Tata Advanced Systems and Satellogic Sign Strategic Contract to Build LEO Satellites in India
AIMD

Business Wire

a year ago

Tata Advanced Systems and Satellogic Sign Strategic Contract to Build LEO Satellites in India

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
AIMD

GlobeNewswire

a year ago

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

AIMD

Business Wire

a year ago

AIM ImmunoTech Provides Update Regarding Annual Meeting

AIMD

ACCESSWIRE

a year ago

Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents
AIMD

GlobeNewswire

a year ago

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents

AIMD

Oilprice.com

a year ago

Indonesia's $20 Billion Leap into Renewable Energy

Implied Volatility Surging for Enviva (EVA) Stock Options
AIMD

Zacks

a year ago

Implied Volatility Surging for Enviva (EVA) Stock Options

20 Most Oxygen Friendly Cities in the US
AIMD

Insider Monkey

a year ago

20 Most Oxygen Friendly Cities in the US

Share on Social Networks: